Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $32.11B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Amgen AMGN:US USD 44.7B 22.52B
AstraZeneca AZN:LN USD 22.27B 327M
Bausch Health Companies Inc VRX:CN USD 4.24B 10M
Biogen BIIB:US USD 9.76B 28.7M
Canopy Growth Corp WEED:CN CAD 1.17B 365.26M
Catalent CTLT:US USD 2.92B 220M
Corcept Therapeutics CORT:US USD 533.89M 34.64M
Drreddys Laboratories RDY:US INR 206.94B 12.45B
Eli Lilly LLY:US USD 20.81B 2.78B
Endo International ENDP:US USD 1.93B 145.01M
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Glaxosmithkline GSK:US GBP 19.72B 1.05B
Horizon Pharma HZNP:US USD 3.6B 50M
J&J JNJ:US USD 64.39B 9.09B
Novartis NOVN:VX USD 32.11B 4.8B
Pacira PCRX:US USD 376.11M 122.22M
Perrigo PRGO:US USD 2.74B 20.8M
Phibro Animal Health PAHC:US USD 585.48M 3.79M
Prestige Brands PBH:US USD 391.74M 17.1M
Roche Holding ROG:VX 33.82B 3.5B
Supernus Pharmaceuticals SUPN:US USD 883.34M 149.19M
Zoetis ZTS:US USD 6.27B 1.24B